Sinco Pharmaceuticals Holdings Limited (6833.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap325.93M
Enterprise Value134.86M
P/E Ratio8.65
PEG Ratio-0.49
Price/Sales Ratio0.14
Price/Book Ratio0.44
Enterprise/Revenue0.05
Enterprise/EBITDA1.15

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0.02
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.05

Income Statement

Revenue2.08B
Revenue/Share1
Gross Profit222.09M
EBITDA93.45M
Net Income34.85M
Diluted EPS0.02

Balance Sheet

Total Cash374.53M
Total Cash/Share0.18
Total Debt183.47M
Total Debt/Equity0.26
Current Ratio1.18
Book Value Per Share0.33

Price History

52-Week Change-24
52-Week High0.26
52-Week Low0.15
Moving Average 50 Days0.17
Moving Average 200 Days0.18

Statistics

Average Volume238,419
Shares Outstanding2.03B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0.98
Payout Ratio0.11
Last Split FactorN/A
Last Split DateN/A
AD